Esperion Therapeutics, Inc.: accounts_receivable
| Value | {"amount": 80142000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2024-12-31) |
| Status | current |
| Entity | Esperion Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T14:06:45.971287+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/316ef156-c83e-4cfd-b482-a8d58734b437
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001628280-25-011154Retrieved: 2026-08-19T14:06:45.971287+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001434868/accounts-receivable/2024-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/316ef156-c83e-4cfd-b482-a8d58734b437
History
- no predecessors — first report